Polyuria
Introduction
Polyuria is a common clinical symptom characterized by the excessive production and excretion of urine, typically defined as a daily urine output exceeding 2.5 to 3 liters in adults. While sometimes a transient and benign condition, polyuria often serves as a significant indicator of underlying health issues, ranging from metabolic imbalances to serious kidney dysfunction. Understanding the biological mechanisms driving this symptom and its genetic predispositions is essential for accurate diagnosis, effective management, and the prevention of associated complications.
Biological Basis
The biological basis of polyuria primarily involves disruptions in the body's intricate systems for fluid balance and kidney function, particularly affecting the endocrine, metabolic, and genitourinary systems. The kidneys are crucial for maintaining water homeostasis and urine concentration, a process regulated by hormones and solute gradients. Genetic variations can influence these regulatory pathways, predisposing individuals to conditions that present with polyuria. For instance, specific genes associated with metabolic disorders like type 2 diabetes (T2D), such as KCNQ1, or chronic kidney disease (CKD), including FTO, CHRM3, STAB1, WDR72, BHLHE22, ABCG2, ZMAT4, MAT2B, and RABGAP1, can directly or indirectly lead to impaired renal function and subsequent polyuria. [1] The cumulative impact of multiple genetic variants, often quantified through polygenic risk scores (PRSs), can also contribute significantly to an individual's susceptibility to diseases that manifest with excessive urination. [1]
Clinical Relevance
From a clinical perspective, polyuria is a critical symptom that prompts medical evaluation for conditions such as diabetes mellitus (type 1 and type 2), diabetes insipidus, chronic kidney disease, and certain electrolyte disturbances. Early identification and genetic risk assessment are vital for preventing severe complications and guiding appropriate treatment strategies. Genome-wide association studies (GWASs) and phenome-wide association studies (PheWASs) are instrumental in identifying genetic variants associated with various traits and diseases, including those linked to polyuria. [1] For example, prevalent conditions in the Taiwanese Han population like T2D, CKD, and gout have established genetic associations that influence their clinical presentation, potentially including polyuria. [1] The integration of polygenic risk scores with clinical features such as age and sex has demonstrated improved accuracy in predicting disease susceptibility, underscoring their potential in advancing clinical diagnostics and personalized medicine. [1]
Social Importance
The social importance of understanding polyuria extends to broad public health initiatives and the advancement of personalized medicine. As a symptom of widespread chronic conditions, polyuria can significantly impact individuals' quality of life and contribute to global healthcare burdens. Research into the genetic architecture of diseases, particularly within diverse populations like the Taiwanese Han, is crucial for addressing the historical underrepresentation of non-European populations in genetic studies. This ensures that genetic risk models, such as PRSs, are robust and applicable across various ancestries, thereby enhancing their predictive power and clinical utility globally. [1] By elucidating the complex interplay of genetic and environmental factors contributing to polyuria and its underlying causes, researchers aim to develop more effective screening programs, preventive measures, and targeted therapies, ultimately improving health outcomes for individuals and communities worldwide.
Generalizability and Ancestry-Specific Genetic Architecture
The findings regarding the genetic architecture of traits, including potential insights into polyuria, are primarily derived from a cohort predominantly of Taiwanese Han ancestry, with some individuals of mixed East Asian descent. [1] While this focus offers valuable insights into specific populations, it inherently limits the generalizability of these associations to individuals of diverse ancestries. Genetic risk factors are often population-specific, and variants common in one population may be rare or absent in others, potentially leading to missed associations or inflated effect sizes when extrapolating findings. [1] Therefore, direct application of these genetic insights for polyuria to non-East Asian populations should be approached with caution, underscoring the necessity for broader ancestral representation in future genetic studies.
Significant differences in minor allele frequencies and effect sizes for specific genetic variants have been observed when comparing the Taiwanese Han population with European cohorts, as exemplified by rs671 in ALDH2 and rs6546932 in SELENOI. [1] Such discrepancies highlight that the genetic architecture underlying complex traits like polyuria can vary substantially across different ancestries. Consequently, polygenic risk score models for polyuria developed in one population may exhibit reduced predictive accuracy when applied to individuals of different genetic backgrounds, emphasizing the critical need for ancestry-specific models to accurately assess disease susceptibility and tailor interventions. [1]
Phenotypic Definition and Cohort Characteristics
The definition of disease phenotypes, including any potential for polyuria, in this study relies on PheCode classification based on Electronic Medical Records (EMRs), which can be influenced by healthcare system practices and the diagnostic decisions of physicians. [1] Although a stringent criterion of three or more diagnoses was implemented to minimize false positives for case ascertainment, this method may not fully capture the nuanced presentation of polyuria or differentiate it from transient symptoms. Future research on polyuria would benefit from more comprehensive phenotyping criteria that integrate diagnosis with medication history and laboratory test results, ensuring greater accuracy and precision in defining cases and controls. [1]
Furthermore, the hospital-centric nature of the HiGenome database introduces a selection bias, as it primarily includes individuals with at least one documented diagnosis, effectively excluding "subhealthy individuals" from the cohort. [1] This characteristic means the study population may not fully represent the general population, potentially limiting the discovery of genetic variants associated with the early stages or milder forms of polyuria, or those that influence its development in otherwise asymptomatic individuals. The absence of a truly healthy reference group could skew observed associations and impact the interpretation of genetic risk factors for polyuria progression. [1]
Incomplete Polygenic Risk Modeling and Environmental Confounders
The predictive power of Polygenic Risk Score (PRS) models for various diseases, which would similarly apply to polyuria, demonstrated modest AUC values, typically around 0.6 for PRS alone, even for well-studied conditions. [1] While the incorporation of age and sex improved model accuracy, the overall predictive performance suggests that the current PRS models may not fully capture the complex genetic contributions to polyuria. The efficacy of PRS models is also acknowledged to be limited by smaller sample sizes, indicating that for traits with fewer affected individuals, the statistical power to detect robust genetic associations for polyuria may be insufficient. [1]
Complex diseases and traits, including polyuria, are understood to result from intricate interactions between multiple genetic variants and a myriad of environmental factors. [1] Although age and sex were adjusted in the models, the study highlights that other crucial clinical features, such as body mass index, blood pressure, glycated hemoglobin level, and various biomarkers, as well as significant environmental factors like exercise, diet, alcohol consumption, and smoking, were not comprehensively integrated into the current PRS models. [1] The omission of these potentially influential confounders and interacting factors represents a knowledge gap, limiting the comprehensive understanding of the full genetic and environmental etiology of polyuria and potentially affecting the accuracy of risk prediction.
Variants
TNFRSF10B (Tumor Necrosis Factor Receptor Superfamily Member 10B), also known as Death Receptor 5 (DR5), is a cell surface receptor that plays a critical role in initiating programmed cell death, or apoptosis, upon binding to its ligand, TRAIL (TNF-related apoptosis-inducing ligand). This gene's function is essential for maintaining cellular homeostasis, as it helps eliminate damaged or abnormal cells, thereby contributing to immune surveillance and tumor suppression. [1] Dysfunction in TNFRSF10B signaling can have broad implications for various physiological systems, including those involved in renal function and fluid balance, which are highly relevant to conditions such as polyuria. Polyuria, characterized by excessive urination, can arise from impaired kidney tubule function, disruptions in hormonal regulation of water reabsorption, or osmotic imbalances, all of which can be indirectly influenced by cellular health and apoptotic pathways. For instance, altered apoptotic pathways in kidney cells could compromise their structural or functional integrity, impairing their ability to properly concentrate urine and leading to increased water excretion. [1]
The specific variant rs56070946 is located within the TNFRSF10B gene. While its precise functional impact requires further investigation, variants in receptor genes like TNFRSF10B can influence several key aspects of protein function, including expression levels, ligand binding affinity, or the efficiency of downstream signaling cascades. Such alterations could subtly affect the delicate balance of cell life and death within renal tissues, potentially contributing to the pathogenesis of polyuria by compromising the ability of nephrons to regulate water reabsorption effectively.
Key Variants
| RS ID | Gene | Related Traits |
|---|---|---|
| rs56070946 | TNFRSF10B | polyuria |
Operational Framework for Trait Definition and Classification
In large-scale genetic studies utilizing electronic medical records, the operational definition and classification of health traits, including conditions like polyuria, are primarily established through standardized nosological systems. The foundational dataset for such analyses typically integrates patient demographics, laboratory results, medical procedures, and diagnostic codes from systems like the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) and Tenth Revision, Clinical Modification (ICD-10-CM). These detailed diagnostic codes are then converted and aggregated into a more manageable set of phenotype codes, known as PheCodes, which serve as a conceptual framework for disease categorization and analysis. [1] This systematic approach allows for a categorical classification of diseases, enabling robust analysis within diverse populations.
Standardized Terminology and Diagnostic Criteria
The nomenclature for clinical conditions in such research adheres to these standardized vocabularies, with ICD-9-CM and ICD-10-CM codes forming the basis for initial data capture. Subsequently, these are mapped to PheCodes, providing a consistent and research-ready terminology for a wide array of traits. For establishing a case definition, clinical diagnoses are considered confirmed when the relevant PheCode criteria are met on at least three distinct occasions, ensuring diagnostic reliability and minimizing false positives. [1] Conversely, control groups are defined by the absence of these PheCode-defined diseases, providing clear criteria for case-control studies.
Genetic Architecture of Renal Function
Polyuria, characterized by the excessive production of urine, is often rooted in an individual's genetic makeup, which dictates the intricate processes of renal function and water balance. Genome-wide association studies (GWAS) have successfully pinpointed numerous genetic loci linked to various kidney function-related traits, highlighting the polygenic nature of renal regulation and an individual's susceptibility to altered urine output. [2] These inherited genetic variants can influence the kidney's ability to concentrate urine or manage solute excretion, thereby directly impacting the volume of urine produced. A broader genetic predisposition has also been identified across different etiologies of chronic kidney disease (CKD) [3] many of which are associated with impaired renal concentrating capacity that can lead to polyuria.
The complex genetic architecture, encompassing both common variants contributing to polygenic risk and, in some cases, rare highly penetrant mutations, dictates an individual's intrinsic susceptibility. While specific Mendelian forms directly causing polyuria were not detailed in the provided context, the impact of genetic variations on ion channels, transporters, or hormonal pathways within the kidneys can severely disrupt fluid homeostasis. This intricate interplay of multiple genes and their collective effects underscores how inherited factors establish the physiological baseline for renal function and an individual's propensity for polyuria.
Comorbidities and Therapeutic Effects
Polyuria can also arise as a direct or indirect consequence of various comorbid health conditions and the effects of medical interventions. Numerous kidney-related disorders, such as IgA nephropathy and membranous nephropathy, can compromise the kidneys' capacity to adequately filter blood and reabsorb fluids, resulting in an increased volume of urine . [3], [4], [5] Similarly, other conditions affecting the urinary tract, like bladder cancer, can indirectly influence urinary patterns, and treatments for such malignancies may further impact renal function and fluid dynamics. [6]
Furthermore, medical therapies, particularly those involving the urinary system or adjacent organs, can induce changes in urine output. For instance, a meta-analysis of GWAS identified genetic markers associated with urinary frequency as a late toxicity following radiotherapy for prostate cancer. [7] While urinary frequency is distinct from polyuria, it often accompanies excessive urine production, indicating a disruption in normal urinary system function post-treatment. These examples illustrate how both underlying health issues and necessary medical procedures can significantly contribute to the development of polyuric symptoms by affecting renal or urinary tract integrity and function.
Developmental Origins and Gene-Environment Dynamics
Early life developmental factors play a crucial role in shaping an individual's long-term renal health and susceptibility to conditions that may lead to polyuria. Congenital anomalies of the urinary tract, such as posterior urethral valves, represent a significant early life influence that can result in impaired renal function throughout an individual's life. [8] These structural abnormalities can lead to chronic kidney issues, predisposing individuals to difficulties in regulating fluid balance and urine production.
While specific environmental factors directly causing polyuria are not explicitly detailed in the provided research, the broader context of genetic studies often illuminates gene-environment interactions. Genetic predispositions, identified through population-specific GWAS in groups such as East Asian populations for kidney function-related traits [2] or in African Americans for other genetic analyses [9] suggest that varying geographic or environmental contexts can interact with genetic backgrounds. These interactions can modulate the risk of developing conditions affecting kidney function and fluid homeostasis, underscoring how an individual's genetic blueprint can be differentially expressed or triggered by environmental cues, ultimately impacting renal physiology and potentially contributing to altered urine output.
Genetic Architecture of Endocrine and Renal System Regulation
The intricate balance of the body's endocrine and genitourinary systems is profoundly shaped by an individual's genetic makeup. Research indicates that specific genetic variants are strongly associated with conditions affecting these crucial regulatory networks. For example, the variant rs2237897 within the KCNQ1 gene is significantly linked to diseases of the endocrine or metabolic systems, such as diabetes mellitus. [1] This highlights how variations in genes involved in metabolic regulation can predispose individuals to systemic imbalances.
Further insights into genetic influences on systemic health come from associations with chronic kidney disease (CKD). Variants like rs56094641 in the FTO gene and rs4148155 in ABCG2 show strong associations with diseases affecting the genitourinary system, including CKD. [1] Additionally, a broader array of genes, such as CHRM3, STAB1, WDR72, BHLHE22, ZMAT4, MAT2B, and RABGAP1, have been identified in relation to CKD. [1] These findings underscore the polygenic nature of renal health, where multiple genetic factors collectively contribute to the function and susceptibility of the genitourinary system.
Systemic Disruptions in Metabolic and Genitourinary Homeostasis
The maintenance of metabolic and genitourinary homeostasis is critical for overall physiological function, and disruptions in these systems can lead to complex health challenges. Conditions such as type 2 diabetes (T2D) exemplify significant imbalances within the endocrine and metabolic systems, affecting essential regulatory processes. [1] Similarly, chronic kidney disease (CKD) represents a substantial disruption within the genitourinary system, impairing its ability to perform vital functions and potentially influencing other interconnected bodily systems. [1] These diseases demonstrate how systemic health relies on the coordinated operation of various organs and tissues.
The observed genetic associations with diseases impacting the circulatory, endocrine, metabolic, and genitourinary systems point to a multifaceted interplay of systemic consequences. [1] For instance, genetic variants linked to CKD are also associated with broader symptoms like abnormal blood chemistry and calculus. [1] This suggests that the pathophysiological processes underlying these conditions are not confined to a single organ but can lead to widespread homeostatic disruptions that necessitate complex compensatory responses throughout the body to maintain essential physiological stability.
Metabolic and Hormonal Pathways in Fluid Homeostasis
Polyuria is often a manifestation of underlying metabolic and endocrine dysregulation, particularly involving glucose and fluid balance. Conditions such as type 2 diabetes (T2D) are frequently associated with polyuria, reflecting imbalances in fluid and solute regulation. Genetic variants in genes like KCNQ1 (rs2237897) are significantly associated with T2D, diabetes mellitus, and hyperlipidemia, implicating their role in metabolic pathways that govern energy metabolism and glucose homeostasis. [1] Similarly, the FTO gene, with its variant rs56094641, is strongly linked to T2D and diseases affecting the endocrine and metabolic systems, suggesting its involvement in metabolic regulation and fat mass and obesity-associated processes that can indirectly impact renal solute handling.
These genes likely influence intracellular signaling cascades critical for insulin sensitivity and glucose uptake, affecting energy metabolism at a systemic level. Dysregulation in these pathways can lead to hyperglycemia, which, when exceeding the renal threshold for glucose reabsorption, results in osmotic diuresis and subsequent polyuria. The intricate feedback loops governing glucose and hormone levels are disrupted, leading to sustained metabolic imbalances that necessitate increased fluid excretion to maintain osmotic equilibrium. Understanding these metabolic pathways and their genetic underpinnings is crucial for elucidating the origins of polyuria in conditions like diabetes.
Renal Transport and Filtration Mechanisms
The kidneys play a central role in maintaining fluid and electrolyte balance, and dysfunctions in renal transport and filtration mechanisms are a direct cause of polyuria. Chronic kidney disease (CKD), for instance, is a prominent condition where impaired renal concentrating ability contributes to excessive urine output. Variants in the FTO gene (rs56094641) are significantly associated with CKD, as well as circulatory, endocrine, and genitourinary systems, highlighting its broader impact on renal function. [1] Another key player is the ABCG2 gene, with its variant rs4148155, strongly associated with CKD, gout, and abnormal blood chemistry, indicating its involvement in solute transport and waste elimination pathways within the kidney. [1]
Beyond these, a suite of genes including CHRM3, STAB1, WDR72, BHLHE22, ZMAT4, MAT2B, and RABGAP1 have also been identified in association with CKD, underscoring the polygenic nature of renal dysfunction. [1] These genes likely modulate various aspects of renal physiology, from glomerular filtration to tubular reabsorption and secretion, influencing the kidney's capacity to concentrate urine. Dysregulation of these proteins, potentially through altered gene expression or post-translational modifications, can impair the intricate balance of water and solute movement, leading to the inability to conserve water effectively and resulting in polyuria.
Genetic Modulators of Organ System Function
Genetic architecture significantly modulates the function of various organ systems, with specific variants influencing disease susceptibility and, consequently, downstream mechanisms leading to polyuria. For example, genes such as CDKAL1 and FTO show significant associations with certain diseases in both Taiwanese Han and European populations, while RSPO3 and AUTS2 exhibit associations unique to the Taiwanese Han population, demonstrating population-specific genetic influences. [1] These genetic differences can lead to variations in protein structure, activity, or expression, thereby altering metabolic or signaling pathways.
Furthermore, ancestry-specific genetic architectures, as exemplified by the SELENOI gene variant rs6546932, which shows different effect sizes across populations, emphasize the importance of population context in understanding disease mechanisms. [1] In the context of alcoholic liver damage (ALD), the ALDH2 variant rs671 is highly prevalent in the Taiwanese Han population and is strongly linked to the BRAP variant rs3782886, which is associated with ALD. [1] Such genetic predispositions can lead to organ damage (e.g., liver), which then triggers systemic changes affecting fluid balance and contributing to polyuria through complex regulatory mechanisms and pathway dysregulation.
Inter-Organ Crosstalk and Pathological Amplification
Polyuria often arises from a complex interplay of dysregulated pathways across multiple organ systems, illustrating pathway crosstalk and network interactions that lead to emergent properties of disease. Diseases like T2D, CKD, gout, and alcoholic liver damage (ALD) are frequently co-occurring and can synergistically contribute to conditions manifesting as polyuria. For instance, metabolic dysfunction in T2D can exacerbate renal damage in CKD, while chronic kidney issues can influence electrolyte balance and systemic inflammation, impacting other organs. This intricate network of interactions highlights how a perturbation in one system can cascade through others, amplifying pathological effects.
The concept of polygenic risk scores (PRSs) further underscores this systems-level integration, summarizing the cumulative effects of multiple genetic variants along with environmental factors to assess disease susceptibility. [1] This integrative approach reveals how polyuria can be an emergent property of multiple interacting dysfunctional pathways, where compensatory mechanisms fail to restore homeostasis. Understanding these complex inter-organ communications and hierarchical regulation is essential for identifying therapeutic targets that address the root causes of polyuria, rather than just its symptomatic presentation.
Risk Assessment for Associated Metabolic and Renal Conditions
The study by Liu et al. highlights the utility of Polygenic Risk Scores (PRSs) in assessing susceptibility to diseases prevalent in the Taiwanese Han population, many of which are directly linked to the etiology of polyuria. [1] For instance, significant genetic associations were identified for type 2 diabetes (T2D) with variants like rs2237897 in KCNQ1, and for chronic kidney disease (CKD) with variants such as rs56094641 in FTO. [1] These findings enable a more nuanced risk stratification for individuals predisposed to T2D or CKD within this specific population, thereby indirectly informing the potential for developing polyuria as a symptom of these conditions. Early identification of high-risk individuals through PRS, especially when combined with clinical features like age and sex, could facilitate personalized medicine approaches and targeted prevention strategies for the underlying diseases. [1]
Enhanced Diagnostic and Monitoring Strategies for Underlying Causes
The integration of polygenic risk scores with traditional clinical features offers enhanced diagnostic utility and informs monitoring strategies for conditions that commonly manifest with polyuria. [1] While PRSs alone often showed moderate predictive power (AUC values typically around 0.6), their combination with clinical factors such as age and sex significantly improved model accuracy, with AUC values for certain traits exceeding 0.9. [1] This suggests that for patients presenting with polyuria, a comprehensive assessment incorporating genetic risk for associated endocrine, metabolic, or genitourinary disorders could refine diagnostic pathways and guide more effective monitoring of disease progression and treatment response for conditions like T2D and CKD. [1] Such an approach supports the long-term management of these underlying conditions, potentially mitigating the severity or recurrence of polyuria.
Comorbidities and Overlapping Phenotypes
The research emphasizes the complex interplay of genetic and environmental factors in polygenic diseases, revealing predominant genetic associations for traits related to endocrine, metabolic, and genitourinary systems. [1] These systems are central to the manifestation of polyuria, which frequently co-occurs with or is a symptom of conditions like diabetes mellitus, hypertension, and chronic kidney disease – diseases for which significant genetic loci were identified in the Taiwanese Han population. [1] The study's broad PheWAS analysis revealed overlapping phenotypes, where variants associated with one disease (e.g., rs56094641 for CKD) also show associations with other relevant traits such as diabetes mellitus and hypertension. [1] This highlights the importance of considering the syndromic presentations and shared genetic architecture among conditions that can lead to polyuria, guiding a holistic clinical assessment.
Frequently Asked Questions About Polyuria
These questions address the most important and specific aspects of polyuria based on current genetic research.
1. My family members pee a lot; will I eventually too?
Yes, there can be a genetic component to conditions that cause excessive urination. Genes like KCNQ1 for type 2 diabetes or a set of genes including FTO and ABCG2 for chronic kidney disease can run in families, predisposing individuals to these conditions, which often feature polyuria. While genetics play a role, it doesn't guarantee you'll develop it, as lifestyle and other factors are also important.
2. Could a genetic test tell me if I'm at risk for peeing too much?
Yes, genetic testing, particularly through polygenic risk scores (PRSs), can assess your susceptibility to conditions associated with polyuria, like type 2 diabetes or chronic kidney disease. These scores combine the effects of multiple genetic variants identified through studies like genome-wide association studies (GWAS). Integrating PRSs with your age and sex can improve the accuracy of predicting your risk, helping with early identification.
3. Does my East Asian heritage change my risk for frequent urination?
Yes, your ancestral background can influence your genetic risk for conditions causing polyuria. Genetic risk factors are often population-specific, meaning variants common in East Asian populations, such as those studied in the Taiwanese Han, might differ in frequency or effect compared to other ancestries. Therefore, genetic risk models need to be tailored to specific populations to accurately predict susceptibility.
4. I drink tons of water; is my frequent peeing just that, or genetic?
While high water intake naturally increases urination, excessive or persistent polyuria could also have an underlying genetic component. Genetic variations can affect your kidneys' ability to concentrate urine or regulate fluid balance, even if you're well-hydrated. Conditions like diabetes, which have strong genetic predispositions involving genes like KCNQ1, can lead to polyuria regardless of fluid intake.
5. Is my increased peeing just age, or a genetic risk?
It can be both. As you age, kidney function can naturally decline, but genetic predispositions can significantly accelerate or worsen this. Genes linked to chronic kidney disease, such as FTO, CHRM3, and ABCG2, can increase your risk, and their impact might become more apparent with age. A genetic assessment alongside clinical factors can offer a clearer picture of your individual risk.
6. Can a healthy lifestyle overcome my genetic risk for peeing too much?
A healthy lifestyle can significantly mitigate genetic risks, but "overcome" might be too strong a word. While your genes can predispose you to conditions like diabetes or kidney disease that cause polyuria, lifestyle choices (diet, exercise) can influence how these genes express themselves. For example, managing your diet can help control blood sugar, even with a genetic predisposition to type 2 diabetes.
7. If I suddenly pee a lot, does it mean I have a genetic problem?
Not necessarily. A sudden increase in urination could be due to many factors, including temporary issues, medication, or lifestyle changes. However, polyuria is a key symptom of several conditions with strong genetic links, such as type 1 or type 2 diabetes, or chronic kidney disease, involving genes like KCNQ1 or FTO. It's important to consult a doctor to determine the cause.
8. Why do some friends pee more than me, with similar habits?
Differences in urination frequency among individuals with similar habits can often be attributed to genetic variations influencing fluid balance and kidney function. Genes like KCNQ1 or those associated with chronic kidney disease (CHRM3, STAB1) can affect how effectively your kidneys regulate water. These genetic differences can lead to varying susceptibilities to conditions that manifest with polyuria.
9. Does stress actually make me pee more, or is it genetic factors?
While stress can sometimes temporarily affect bladder function, persistent excessive urination is more often linked to underlying biological or genetic factors. Genes that regulate metabolic processes or kidney function, such as KCNQ1 for diabetes or WDR72 for kidney disease, play a more significant role in chronic polyuria. Stress might exacerbate symptoms, but it's unlikely to be the primary cause of genetic-related polyuria.
10. Can what I eat contribute to my risk of conditions causing polyuria?
Yes, your diet plays a significant role, especially in conditions like type 2 diabetes, which has a strong genetic component and often causes polyuria. While genes like KCNQ1 predispose you, a diet high in processed foods or sugars can trigger or worsen diabetes, leading to increased urination. Eating a balanced diet can help manage these risks, even with genetic predispositions.
This FAQ was automatically generated based on current genetic research and may be updated as new information becomes available.
Disclaimer: This information is for educational purposes only and should not be used as a substitute for professional medical advice. Always consult with a healthcare provider for personalized medical guidance.
References
[1] Liu, T. Y. "Diversity and longitudinal records: Genetic architecture of disease associations and polygenic risk in the Taiwanese Han population." Sci Adv, vol. 11, no. 22, 4 June 2025, p. eadt0539. PMID: 40465716.
[2] Okada, Y. et al. "Meta-analysis identifies multiple loci associated with kidney function-related traits in east Asian populations." Nat Genet, 2012.
[3] Sekula, P. et al. "Genetic risk variants for membranous nephropathy: extension of and association with other chronic kidney disease aetiologies." Nephrol Dial Transplant, 2016.
[4] Kiryluk, K. et al. "Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy." Nat Genet, 2023.
[5] Xie, J. et al. "The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis." Nat Commun, 2020.
[6] Rothman, N. et al. "A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci." Nat Genet, 2009.
[7] Kerns, SL. et al. "Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer." EBioMedicine, 2016.
[8] van der Zanden, LFM. et al. "Genome-wide association study in patients with posterior urethral valves." Front Pediatr, 2023.
[9] Batai, K. et al. "Genetic loci associated with skin pigmentation in African Americans and their effects on vitamin D deficiency." PLoS Genet, 2021.